» Articles » PMID: 36157062

Bioinformatics Prediction and Experimental Verification of Key Biomarkers for Diabetic Kidney Disease Based on Transcriptome Sequencing in Mice

Overview
Journal PeerJ
Date 2022 Sep 26
PMID 36157062
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetic kidney disease (DKD) is the leading cause of death in people with type 2 diabetes mellitus (T2DM). The main objective of this study is to find the potential biomarkers for DKD.

Materials And Methods: Two datasets (GSE86300 and GSE184836) retrieved from Gene Expression Omnibus (GEO) database were used, combined with our RNA sequencing (RNA-seq) results of DKD mice (C57 BLKS-32w db/db) and non-diabetic (db/m) mice for further analysis. After processing the expression matrix of the three sets of data using R software "Limma", differential expression analysis was performed. The significantly differentially expressed genes (DEGs) (-logFC- > 1, -value < 0.05) were visualized by heatmaps and volcano plots respectively. Next, the co-expression genes expressed in the three groups of DEGs were obtained by constructing a Venn diagram. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were further analyzed the related functions and enrichment pathways of these co-expression genes. Then, qRT-PCR was used to verify the expression levels of co-expression genes in the kidney of DKD and control mice. Finally, protein-protein interaction network (PPI), GO, KEGG analysis and Pearson correlation test were performed on the experimentally validated genes, in order to clarify the possible mechanism of them in DKD.

Results: Our RNA-seq results identified a total of 125 DEGs, including 59 up-regulated and 66 down-regulated DEGs. At the same time, 183 up-regulated and 153 down-regulated DEGs were obtained in GEO database GSE86300, and 76 up-regulated and 117 down-regulated DEGs were obtained in GSE184836. Venn diagram showed that 13 co-expression DEGs among the three groups of DEGs. GO analysis showed that biological processes (BP) were mainly enriched inresponse to stilbenoid, response to fatty acid, response to nutrient, positive regulation of macrophage derived foam cell differentiation, triglyceride metabolic process. KEGG pathway analysis showed that the three major enriched pathways were cholesterol metabolism, drug metabolism-cytochrome P450, PPAR signaling pathway. After qRT-PCR validation, we obtained 11 genes that were significant differentially expressed in the kidney tissues of DKD mice compared with control mice. (The mRNA expression levels of Aacs, Cpe, Cd36, Slc22a7, Slc1a4, Lpl, Cyp7b1, Akr1c14 and Apoh were declined, whereas Abcc4 and Gsta2 were elevated).

Conclusion: Our study, based on RNA-seq results, GEO databases and qRT-PCR, identified 11 significant dysregulated DEGs, which play an important role in lipid metabolism and the PPAR signaling pathway, which provide novel targets for diagnosis and treatment of DKD.

Citing Articles

Comprehensive Analysis Reveals the Potential Diagnostic Value of Biomarkers Associated With Aging and Circadian Rhythm in Knee Osteoarthritis.

Li H, Yang Y, Li B, Yang J, Liu P, Gao Y Orthop Surg. 2025; 17(3):922-938.

PMID: 39846237 PMC: 11872380. DOI: 10.1111/os.14370.


Investigation of Scutellaria Barbata's immunological mechanism against thyroid cancer using network pharmacology and experimental validation.

Ouyang G, Zhu Y, Ouyang Z Sci Rep. 2025; 15(1):2490.

PMID: 39833432 PMC: 11747344. DOI: 10.1038/s41598-025-86733-1.


Bioinformatic analyses reveal lysosomal-associated protein transmembrane 5 as a potential therapeutic target in lipotoxicity-induced injury in diabetic kidney disease.

Chen X, Zhu S, Huang C, Liu J, Wang J, Cui S Ren Fail. 2024; 46(2):2359638.

PMID: 38832484 PMC: 11151807. DOI: 10.1080/0886022X.2024.2359638.


The Influence of Soy Isoflavones and Soy Isoflavones with Inulin on Kidney Morphology, Fatty Acids, and Associated Parameters in Rats with and without Induced Diabetes Type 2.

Misiakiewicz-Has K, Maciejewska-Markiewicz D, Szypulska-Koziarska D, Kolasa A, Wiszniewska B Int J Mol Sci. 2024; 25(10).

PMID: 38791455 PMC: 11121859. DOI: 10.3390/ijms25105418.


Lipid metabolism disorder in diabetic kidney disease.

Han Y, Du B, Zhu X, Wang Y, Zheng H, Liu W Front Endocrinol (Lausanne). 2024; 15:1336402.

PMID: 38742197 PMC: 11089115. DOI: 10.3389/fendo.2024.1336402.


References
1.
Alkhatatbeh M, Enjeti A, Acharya S, Thorne R, Lincz L . The origin of circulating CD36 in type 2 diabetes. Nutr Diabetes. 2013; 3:e59. PMC: 3584987. DOI: 10.1038/nutd.2013.1. View

2.
Gao Z, S A, Li X, Li X, Sui L . Identification of Key Candidate Genes and Chemical Perturbagens in Diabetic Kidney Disease Using Integrated Bioinformatics Analysis. Front Endocrinol (Lausanne). 2021; 12:721202. PMC: 8453249. DOI: 10.3389/fendo.2021.721202. View

3.
Hasegawa S, Noda K, Maeda A, Matsuoka M, Yamasaki M, Fukui T . Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels. Mol Genet Metab. 2012; 107(3):553-60. DOI: 10.1016/j.ymgme.2012.08.017. View

4.
Hong Q, Zhang L, Fu J, Verghese D, Chauhan K, Nadkarni G . LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF--Induced Angiogenesis. J Am Soc Nephrol. 2019; 30(4):546-562. PMC: 6442349. DOI: 10.1681/ASN.2018060599. View

5.
Hasstedt S, Coon H, Xin Y, Adams T, Hunt S . APOH interacts with FTO to predispose to healthy thinness. Hum Genet. 2015; 135(2):201-7. PMC: 4715708. DOI: 10.1007/s00439-015-1629-3. View